Please assess the completion status of the following clinical trial:

Trial Title: Eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES):

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Currently 34 weeks pregnant or within 6 weeks postpartum~2. At least 18 years of age~3. Singleton or twin gestation~4. Patient or family sign informed consent~5. Diagnosis of eclampsia~6. Able to obtain MRI scanning within 24hours of hosp admit and/or seizure~Exclusion Criteria:~1. Neither pregnant nor within first 6 weeks postpartum~2. Patient or family unable to sign informed consent~3. Less than 18 years of age~4. Triplet or higher order gestation~5. Unable to obtain MRI scanning within 24 hours of hospital admission (~6. Diagnosis of cerebral hemorrhage~7. Patient in whom MRI is contraindicated

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Dexamethasone (Type: ACTIVE_COMPARATOR): Dexamethasone 12 mg, 2 doses, 12 hours apart.
- Placebo (Type: PLACEBO_COMPARATOR): Placebo, 2 doses, 12 hours apart

Based on this trial design, predict the completion outcome and termination type (if applicable).